Hydrocodone/aspirin
Hydrocodone/aspirin (INNs) is an oral combination drug formulation of the opioid analgesic hydrocodone and the nonsteroidal anti-inflammatory drug (NSAID) aspirin that is used in the treatment of chronic and acute pain.[1] It is sold under brand names including Alor 5/500, Azdone, Damason-P, Lortab ASA, and Panasal 5/500.
| Combination of | |
|---|---|
| Hydrocodone | Opioid analgesic |
| Aspirin | NSAID |
| Clinical data | |
| Trade names | Alor 5/500, Azdone, Damason-P, Lortab ASA, Panasal 5/500 |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
References
- Jan Odom-Forren; Cecil Drain (11 February 2008). PeriAnesthesia Nursing: A Critical Care Approach. Elsevier Health Sciences. pp. 751–. ISBN 1-4377-2610-0.
Opioid receptor modulators | |
|---|---|
| MOR |
|
| DOR |
|
| KOR |
|
| NOP |
|
| Unsorted |
|
| Others |
|
See also: Receptor/signaling modulators • Signaling peptide/protein receptor modulators | |
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.